Determination of pro-inflammatory and humoral factors in gonarthrosis in women with hypertension and overweight
DOI:
https://doi.org/10.34287/MMT.1(52).2022.5Abstract
Purpose of the study. The purpose of the work. to study the influence of pro-inflammatory cytokines and neurohumoral factors of adipose tissue on the pathogenesis of HA in women with NM and hypertension to further improve the effectiveness of treatment of this group of patients.
Materials and methods. We examined 198 women with GA and GA in combination with GC and NM aged 40 to 70 years (average - 62.6 ± 1.9 years) with a disease duration of an average of 13.4 ± 3.8 years. In order to analyze the impact of comorbid pathology on the underlying disease, all surveyed women were divided into three groups. The first group (G1) included 59 women with symptoms of HA without concomitant pathology, the second (G2) group - 74 women with HA and GC, and the third (G3) 65 women with HA and GC and NM. All patients underwent standard general clinical examination. In order to study the neurohumoral aspects of the disease, enzyme-linked immunosorbent assay of C-reactive protein, tumor necrosis factor, interleukin-1beta, interleukin 6, interleukin 10 and leptin was performed.
Results. It was found that the combination of excess weight with the course of HA leads to a more significant increase in the production of proinflammatory cytokines compared with patients with HA without concomitant pathology (p <0.05). Direct correlations have been established between weight gain and increased levels of proinflammatory cytokines and adipose tissue neurohumoral factors.
Conclusions. The combination of inflammatory and destructive changes in the joints in HA with weight gain and increased blood pressure, creates conditions for the development of severe immunological disorders in patients and requires pharmacological correction.
References
Golovach IYu. The role of symptom- modifying and structural-modifying drugs in 30 the treatment of osteoarthritis: the place of non- saponifying phytosterols. Trauma. 2015; 1: 15–21.
Babak OYa, Kravchenko NA, Vinogradova SV Correction of insulin resistance, dyslipidemia and arterial hypertension in metabolic syndrome and type 2 diabetes mellitus. Ukrainian Therapeutic Journal. 2008; 3: 4–6.
IV Guzhevsky, SI Gerasimenko, AA Magomedov [etc.] On the question of local treatment of some types of primary gonarthrosis in adults. Ukr. magazine clinical and laboratory medicine.2009; (4) 1: 70–74.
Dmitriev AL Disorders of metabolism in cartilage and bone tissue in hypokinesia and degenerative-dystrophic diseases of the musculoskeletal system. Journal of Grodno State Medical University. 2010; 3 (31): 20–23.
Leontieva FS, DV Morozenko, KV Makolinets Biochemical markers in the diagnosis of osteoarthritis. International Medical Journal. 2013; 2: 76–78.
Luchikhina EL Prediction and long-term maintenance of low disease activity against the background of therapy with genetically engineered biological drugs in rheumatoid arthritis. Modern rheumatology. 2014; 2: 55–59.
Aleksenko EYu, AV Govorin Evaluation of inflammatory markers and oxidative stress indicators in patients with osteoarthritis in combination with hypertension Siberian Medical Journal. 2011; (26); 1: 54–58.
Bereznyakov IG, IV Korzh Osteoarthritis, arterial hypertension and obesity: the problem of comorbidity. International Medical Journal. 2012; 4: 78–81.
Nüesch E, Dieppe P, Reichenbach S [et al.].All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ. 2011; 342p.
Cao JJ. Effects of obesity on bone metabolism.J. Orthop. Surg. Res.2011;6 (30):30–36.
Henrotin Y. Advances in the treatment of osteoarthritis and role of chondroitin sulphate – a review.Ther. Adv. Musculosceletal Dis.2010;2 (6): 335–348.
du Souich P, García AG, Vergés J [et al.]. Immunomodulatory and anti inflammatory effects of chondroitin sulphate.J. Cell. Mol. Med.2009;13 (8a): 1451–1463.
Lago R, Gomez R, Lago F [et al.]. Leptin beyond body weight regulation – current concepts concerning its role in immune function and inflammation.Cell. Immunol.2008;252 (1–2):139–145.
Wang X, Hunter D, Xu J [et al.]Metabolic triggered inflammation in osteoarthritis. Osteoarthritis Cartilage. 2015;23:1:22–30.
